跳至主要内容
临床试验/NCT06220266
NCT06220266招募中2 期

Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women

Dhurakij Pundit University1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2024年3月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
10
试验地点
1
主要终点
Serum lipid parameters

研究概览

简要总结

The goal of this clinical trial is to learn about the effects of phytoestrogen from Pueraria Mirifica in improvement of serum lipid parameters. The primary question it aims to answer are:

• phytoestrogen from Pueraria Mirifica can reduce serum triglyceride, total cholesterol, LDL and increase HDL or not

Participants will receive capsules which composed of dry weight 50 mg of Pueraria Mirifica twice a day for 2 months. Researchers will compare with diet control&life style modification to see if there is the improvement of serum lipid parameters

详细描述

The secondary question it aims to answer are:

  • phytoestrogen from Pueraria Mirifica can reduce menopausal symptom score or not
  • phytoestrogen from Pueraria Mirifica can reduce body mass index(BMI) or not
  • phytoestrogen from Pueraria Mirifica can reduce waist circumference or not
  • phytoestrogen from Pueraria Mirifica can reduce blood pressure or not
  • phytoestrogen from Pueraria Mirifica effects to creatinine, BUN, eGFR or not
  • phytoestrogen from Pueraria Mirifica effects liver function enzymes or not

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

Unmasked due to patient preference trial

入排标准

性别
Female
接受健康志愿者

入选标准

  • Natural menopause, last menstrual period more than one year ago.
  • Abnormal lipid profile parameters The criteria set for this research are:
  • LDL>130 mg/Dl or
  • TG>150 mg/Dl or
  • Total cholesterol>200 mg/Dl or
  • HDL-C less than 50 mg/Dl. (Latest blood results not more than 6 months)
  • Willing to participate in the project

排除标准

  • Have ever received lipid-lowering medication or hormone replacement therapy or SERMs. During the past 6 weeks
  • have had surgery on the ovaries or uterus before
  • have a history of cancer within a 5-year period
  • have diabetes or uncontrolled high blood pressure, including HbA1c >9, Systolic blood pressure >180 or Diastolic blood pressure >110
  • Endocrine system disease such as thyroid
  • Ever had an organ transplant
  • Regularly use drugs, marijuana, or drink alcohol.
  • has a psychiatric disorder
  • have other serious medical conditions that require close monitoring
  • Inconvenient to follow up until the end of the research.

研究组 & 干预措施

PM

Experimental

Pueraria mirifica

干预措施: Phytoestrogen (Drug)

Diet control & life style modification

Placebo Comparator

Diet control & life style modification

干预措施: Diet control & life style modification (Drug)

结局指标

主要结局

Serum lipid parameters

时间窗: 2 months

serum triglyceride, total cholesterol, LDL, HDL

次要结局

  • Blood Pressure(2 months)
  • Body mass index(BMI) or body weight(2 months)
  • Menopause symptom score(2 months)
  • liver enzymes(2 months)
  • waist circumference(2 months)
  • kidney function(2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prischa Saengow

medical doctor

Dhurakij Pundit University

研究点 (1)

Loading locations...

相似试验